Cornelia Beier
Co-founder Shareholder @Leon-Nanodrugs
Signup · Get unlimited contacts
WORK HISTORY
Co-founder Shareholder @Leon-Nanodrugs
Munich, US
develops new and advanced manufacturing devices to facilitate nano encapsulation for fast, easy, efficient and highly flexible GMP manufacturing solutions, from lab development to commercial supply.LEON is revolutionizing the nanoencapsulation for personalized medicine.Current manufacturing of individual batches is extremely expensive. In addition the low throughput is a major hurdle for broader application.Solution: LEON is engineering disruptive systems to make personalized medicines widely available for the global population in a timely fashion and at affordable prices, bya) enabling small development companies and their investors to manufacture clinical trial material fast and cost-efficient b) enabling CDMOs* to set up centralized manufacturing of individual batch manufacturing as a valuable businessc) broadening access to encapsulated in-vivo gene therapies by easy manufacturing routines and affordable manufacturing costsd) paving the way for future bedside manufacturing of personalized Cell & Gene Therapy products.The combination of a superior technology and GMP compliant systems makes LEON unique.LEON is active in one of the most attractive future markets. Disposable operational unit (consumable) will drive the value.
EDUCATION
Westdeutsche Akademie Kommunikation, Essen, Germany
Certificate Marketing / Communications
ABOUT CORNELIA BEIER
Serial entrepreneur, investment- and strategy consultant in life science industry, pharmaceutical development and digital health. Special interest: innovative projects in life science industry, consumer health, sustainability, prevention projects in cancer, healthy lifestyle, charity, philanthropy and donation projects in healthcare.Boosting Health Ventures “Health and life sciences is our passion. We empower entrepreneurs to create successful companies!”Consulting | M&A | Management I FinancingAt CB1, we bring a wealth of experience and a finely honed skill set to bolster health and life science start-ups on their journey towards becoming thriving enterprises. CB1 has built a portfolio of companies in the field of digital health and pharmaceutical reformulations.Our success is underpinned by a robust network comprised of exceptional scientists, visionary entrepreneurs, forward-thinking investors, dynamic startups, and passionate individuals who share our vision for a brighter and healthier future.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.